Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Inogen Logo
Inogen Growth Score
46
CB Rank
178841
Heat Score
33
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Founded
obfuscation
PublicPost-IPO Equity Goleta, California, United States251-500 provider.inogen.com/
Health Care
Manufacturing
Medical Device
Overview

Inogen
Total Funding
obfuscation
Growth Score
46
Heat Score
33

Total Funding
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score46
-3 pts
in past quarter
Heat Score 33
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Inogen

CB Rank
178841
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Founded
obfuscation
PublicPost-IPO Equity Goleta, California, United States251-500 provider.inogen.com/
Health Care
Manufacturing
Medical Device

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Inogen, Inc.
Operating Status Active
Stock Symbol  NASDAQ:INGN
Company Type For Profit
Founders  Alison Bauerlein, Brenton Taylor, Byron Myers
About the Company

Inogen is innovation in oxygen therapy. Our mission is to improve freedom and independence for oxygen therapy patients through innovative products and services. As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior

service to those users in their homes.

Phone Number 8774458478
Contact Email info@inogen.net
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
Inogen is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Inogen Rove 6
A portable oxygen concentrator providing pulse-dose oxygen delivery with up to 6 flow settings and extended battery life for mobility and travel.
Inogen Rove 4
A compact portable oxygen concentrator offering pulse-dose oxygen delivery with four flow settings and multiple battery options for daily use and travel.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity
obfuscation
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
1
obfuscation
Yuwell MedicalPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Yuwell Medical Logo
Yuwell Medical
Yes
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
Alex WU
Yuwell Medical Logo
Yuwell Medical
Yes
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
Alex WU
Yuwell Medical Logo
Yuwell Medical
Yes
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
Alex WU
Yuwell Medical Logo
Yuwell Medical
Yes
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
Alex WU
Yuwell Medical Logo
Yuwell Medical
Yes
Post-IPO Equity - Inogen Logo
Post-IPO Equity - Inogen
Alex WU

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 8 Board Members and Advisors 12 Contacts 563

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$220KThis year, Inogen is projected to spend $220K on IT, according to Aberdeen.

Active Website Tech Count

34Inogen is actively using 34 technologies for its website, according to BuiltWith. These include Common Crawl, SSL by Default, and  CommonCrawl Top 50m.

Total IP

93The intellectual property of Inogen includes 61 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Inogen has registered 32 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Inogen's headquarters? Inogen is located in Goleta, California, United States.Who invested in Inogen? Inogen has 6 investors including Yuwell Medical and  Novo Holdings.When was the last funding round for Inogen? Inogen closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Inogen's competitors? Alternatives and possible competitors to Inogen may include Nidek Medical, OxygenPlus Medical Systems, and  Cornerstone Medical.How much funding has Inogen raised to date? Inogen has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|